(0.23%) 5 192.90 points
(0.15%) 38 909 points
(0.17%) 16 377 points
(-0.51%) $78.08
(0.23%) $2.20
(-0.29%) $2 324.50
(-0.18%) $27.57
(2.43%) $988.30
(-0.01%) $0.928
(0.44%) $10.87
(0.17%) $0.797
(0.11%) $91.45
0.35% $ 2.84
Live Chart Being Loaded With Signals
Probiotec Limited engages in the development, manufacture, packing, and sale of pharmaceuticals, consumer health, and fast-moving consumer products in Australia and internationally...
Stats | |
---|---|
Volumen de hoy | 420.00 |
Volumen promedio | 113 370 |
Capitalización de mercado | 230.96M |
EPS | $0 ( 2024-02-26 ) |
Próxima fecha de ganancias | ( $0 ) 2024-05-29 |
Last Dividend | $0.0350 ( 2023-08-31 ) |
Next Dividend | $0 ( N/A ) |
P/E | 28.40 |
ATR14 | $0.00700 (0.25%) |
Probiotec Ltd Correlación
10 Correlaciones Más Positivas |
---|
10 Correlaciones Más Negativas |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Probiotec Ltd Finanzas
Annual | 2023 |
Ingresos: | $214.03M |
Beneficio Bruto: | $61.61M (28.78 %) |
EPS: | $0.140 |
FY | 2023 |
Ingresos: | $214.03M |
Beneficio Bruto: | $61.61M (28.78 %) |
EPS: | $0.140 |
FY | 2022 |
Ingresos: | $182.33M |
Beneficio Bruto: | $54.81M (30.06 %) |
EPS: | $0.170 |
FY | 2021 |
Ingresos: | $120.51M |
Beneficio Bruto: | $38.70M (32.11 %) |
EPS: | $0.0783 |
Financial Reports:
No articles found.
Probiotec Ltd Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0.0350 (N/A) |
$0 (N/A) |
$0.0300 (N/A) |
$0 (N/A) |
$0.0350 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | $0.0100 | 2008-02-28 |
Last Dividend | $0.0350 | 2023-08-31 |
Next Dividend | $0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 22 | -- |
Total Paid Out | $0.455 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 3.56 | -- |
Div. Sustainability Score | 10.00 | |
Div.Growth Potential Score | 3.91 | |
Div. Directional Score | 7.80 | -- |
Year | Amount | Yield |
---|
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
GDG.AX | Ex Dividend Junior | 2023-09-08 | Semi-Annually | 0 | 0.00% | |
QRI.AX | Ex Dividend Junior | 2023-09-05 | Monthly | 0 | 0.00% | |
BBN.AX | Ex Dividend Knight | 2023-08-24 | Semi-Annually | 0 | 0.00% | |
JBH.AX | Ex Dividend Knight | 2023-08-24 | Semi-Annually | 0 | 0.00% | |
SKC.AX | Ex Dividend Knight | 2023-09-07 | Annually | 0 | 0.00% | |
CIA.AX | Ex Dividend Knight | 2023-06-13 | Semi-Annually | 0 | 0.00% | |
MND.AX | Ex Dividend Knight | 2023-09-07 | Semi-Annually | 0 | 0.00% | |
VEA.AX | Ex Dividend Knight | 2023-09-05 | Semi-Annually | 0 | 0.00% | |
DJW.AX | Ex Dividend Knight | 2023-08-10 | Semi-Annually | 0 | 0.00% | |
OPH.AX | No Dividend Player | 2023-06-30 | Annually | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.0393 | 1.500 | 9.21 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0375 | 1.200 | 8.75 | 10.00 | [0 - 0.3] |
returnOnEquityTTM | 0.0990 | 1.500 | -0.0111 | -0.0166 | [0.1 - 1] |
payoutRatioTTM | 0.609 | -1.000 | 3.91 | -3.91 | [0 - 1] |
currentRatioTTM | 1.579 | 0.800 | 7.11 | 5.68 | [1 - 3] |
quickRatioTTM | 1.034 | 0.800 | 8.62 | 6.90 | [0.8 - 2.5] |
cashRatioTTM | 0.279 | 1.500 | 9.56 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.223 | -1.500 | 6.29 | -9.43 | [0 - 0.6] |
interestCoverageTTM | 3.16 | 1.000 | 9.94 | 9.94 | [3 - 30] |
operatingCashFlowPerShareTTM | 0.192 | 2.00 | 9.94 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 0.0591 | 2.00 | 9.97 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.584 | -1.500 | 7.66 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.272 | 1.000 | 8.81 | 8.81 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.0859 | 1.000 | -0.281 | -0.281 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.304 | 1.000 | 9.42 | 9.42 | [0.2 - 2] |
assetTurnoverTTM | 0.956 | 0.800 | 6.96 | 5.57 | [0.5 - 2] |
Total Score | 11.69 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 26.50 | 1.000 | 7.42 | 0 | [1 - 100] |
returnOnEquityTTM | 0.0990 | 2.50 | -0.00712 | -0.0166 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 0.0591 | 2.00 | 9.98 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 2.47 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 0.192 | 2.00 | 9.94 | 10.00 | [0 - 30] |
payoutRatioTTM | 0.609 | 1.500 | 3.91 | -3.91 | [0 - 1] |
pegRatioTTM | 0.157 | 1.500 | -2.29 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.0708 | 1.000 | -0.731 | 0 | [0.1 - 0.5] |
Total Score | 3.91 |
Probiotec Ltd
Probiotec Limited engages in the development, manufacture, packing, and sale of pharmaceuticals, consumer health, and fast-moving consumer products in Australia and internationally. The company provides contract manufacturing services for solid dose tablets, capsules, and caplets; tablets coating; blister packing; liquids, creams, gels, ointments, and suspensions; powders and powder blending; and sprays, as well as manufactures and packages finished doses. It also offers analytical and stability testing services; new product formulation and production trials, and ongoing research and development services; and packaging options for human and animal nutrition products, as well as manufactures and exports a range of nutraceuticals and functional ingredient raw materials. The company was incorporated in 1996 and is headquartered in Laverton North, Australia.
Acerca de Señales en Vivo
Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.
Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico